-
Mashup Score: 1
Indian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on Thursday, driven by strong sales, especially in the key North American market.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Japan’s Takeda Pharmaceutical said full-year earnings slumped by more than half as the company focused on rebuilding its drug pipeline to make up for the loss of patent protection for major sellers.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge’s heart devices in patients as they faced safety and quality concerns despite a string of recalls.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates - 10 hour(s) ago
Teva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie’s blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge’s heart devices in patients as they faced safety and quality concerns despite a string of recalls.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
Health and wellness products retailer Vitamin Shoppe said on Wednesday that subscribers to its telehealth service would have access to weight-loss medications such as Ozempic, Mounjaro and Rybelsus.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates - 14 hour(s) ago
Teva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie’s blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
Regeneron Pharmaceuticals said on Wednesday its investigational gene therapy improved hearing to normal levels in a child within 24 weeks in an early to mid-stage study.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
The U.S Food and Drug Administration on Wednesday recommended healthcare facilities transition away from using Getinge’s heart devices as they continued to have safety and quality concerns.
Source: www.reuters.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1
Health and wellness products retailer Vitamin Shoppe said on Wednesday that subscribers to its telehealth service would have access to weight-loss medications such as Ozempic, Mounjaro and Rybelsus.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
Indian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on Thursday, driven by strong sales, especially in the key North American market. https://t.co/0U6H07ySQO https://t.co/0U6H07ySQO